• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.万古霉素治疗改变艰难梭菌感染老年小鼠模型中的体液免疫和肠道微生物群。
J Infect Dis. 2016 Jul 1;214(1):130-9. doi: 10.1093/infdis/jiw071. Epub 2016 Feb 24.
2
Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.口服万古霉素治疗艰难梭菌定植患者的随机对照试验。
mSphere. 2021 Jan 13;6(1):e00936-20. doi: 10.1128/mSphere.00936-20.
3
Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.口腔 fidaxomicin 给药对小鼠肠道微生物群和艰难梭菌定植易感性的影响。
Antimicrob Agents Chemother. 2018 Apr 26;62(5). doi: 10.1128/AAC.02112-17. Print 2018 May.
4
Collateral damage during antibiotic treatment of C. difficile infection in the aged host: Insights into why recurrent disease happens.老年宿主艰难梭菌感染抗生素治疗中的附带损害:复发疾病发生的原因分析。
Gut Microbes. 2017 Sep 3;8(5):504-510. doi: 10.1080/19490976.2017.1323616. Epub 2017 Apr 28.
5
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.万古霉素治疗与小鼠肠道组织损伤延迟、梭状芽孢杆菌过度生长和艰难梭菌感染复发的关系。
Antimicrob Agents Chemother. 2013 Feb;57(2):689-96. doi: 10.1128/AAC.00877-12. Epub 2012 Nov 12.
6
Enhanced preservation of the human intestinal microbiota by ridinilazole, a novel Clostridium difficile-targeting antibacterial, compared to vancomycin.利奈唑胺对艰难梭菌具有靶向抗菌作用,与万古霉素相比,可增强对人类肠道微生物群的保护。
PLoS One. 2018 Aug 2;13(8):e0199810. doi: 10.1371/journal.pone.0199810. eCollection 2018.
7
Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment.小檗碱可阻止C57BL/6小鼠在标准万古霉素治疗后艰难梭菌感染的复发。
Antimicrob Agents Chemother. 2015 Jul;59(7):3726-35. doi: 10.1128/AAC.04794-14. Epub 2015 Mar 30.
8
Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.艰难梭菌感染啮齿动物模型中的疾病进展与消退以及抗毒素抗体和万古霉素的影响
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6471-6482. doi: 10.1128/AAC.00974-16. Print 2016 Nov.
9
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.短链 Ceragenin CSA13 通过调节肠道微生物组和代谢物减少小鼠艰难梭菌感染。
Gastroenterology. 2018 May;154(6):1737-1750. doi: 10.1053/j.gastro.2018.01.026. Epub 2018 Jan 31.
10
The gut microbiome diversity of Clostridioides difficile-inoculated mice treated with vancomycin and fidaxomicin.艰难梭菌定植小鼠经万古霉素和非达霉素治疗后的肠道微生物多样性。
J Infect Chemother. 2020 May;26(5):483-491. doi: 10.1016/j.jiac.2019.12.020. Epub 2020 Mar 9.

引用本文的文献

1
toxin A and toxin B inhibit toxin-specific adaptive immune responses through glucosyltransferase-dependent activity.毒素A和毒素B通过依赖葡萄糖基转移酶的活性抑制毒素特异性适应性免疫反应。
bioRxiv. 2025 Aug 2:2025.07.30.667646. doi: 10.1101/2025.07.30.667646.
2
Early life microbiome disbalance impacts neuroendocrine outcomes in pre-pubertal mice in a sexually dimorphic manner.早期生命微生物群失衡以性别二态性方式影响青春期前小鼠的神经内分泌结果。
Front Microbiol. 2025 Jun 20;16:1504513. doi: 10.3389/fmicb.2025.1504513. eCollection 2025.
3
IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity.白细胞介素-33通过恢复体液免疫来预防艰难梭菌反复感染。
J Clin Invest. 2025 Mar 6;135(9). doi: 10.1172/JCI184659. eCollection 2025 May 1.
4
IL-33 protects from recurrent infection by restoration of humoral immunity.白细胞介素-33通过恢复体液免疫来预防反复感染。
bioRxiv. 2024 Nov 17:2024.11.16.623943. doi: 10.1101/2024.11.16.623943.
5
Antibiotic-induced gut microbiota disruption promotes vascular calcification by reducing short-chain fatty acid acetate.抗生素诱导的肠道微生物菌群紊乱通过减少短链脂肪酸乙酸盐促进血管钙化。
Mol Med. 2024 Aug 24;30(1):130. doi: 10.1186/s10020-024-00900-0.
6
A Streamlined Method to Obtain Biologically Active TcdA and TcdB Toxins from .从. 中获得具有生物活性的 TcdA 和 TcdB 毒素的简化方法
Toxins (Basel). 2024 Jan 11;16(1):38. doi: 10.3390/toxins16010038.
7
Correlating Antibiotic-Induced Dysbiosis to Spore Germination and Host Susceptibility to Infection Using an Assay.利用一种检测方法将抗生素诱导的菌群失调与孢子萌发和宿主易感性感染相关联。
ACS Infect Dis. 2023 Oct 13;9(10):1878-1888. doi: 10.1021/acsinfecdis.3c00192. Epub 2023 Sep 27.
8
Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.长期使用抗生素会导致系统性真菌感染后死亡率升高,其机制为驱动淋巴细胞功能障碍和共生菌的全身逃逸。
Cell Host Microbe. 2022 Jul 13;30(7):1020-1033.e6. doi: 10.1016/j.chom.2022.04.013. Epub 2022 May 13.
9
Teaching old mice new tricks: the utility of aged mouse models of C. difficile infection to study pathogenesis and rejuvenate immune response.教老老鼠新把戏:艰难梭菌感染的老年小鼠模型在研究发病机制和恢复免疫反应方面的应用。
Gut Microbes. 2021 Jan-Dec;13(1):1966255. doi: 10.1080/19490976.2021.1966255.
10
Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology.粪便微生物群移植治疗艰难梭菌感染:机制与药理学。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):67-80. doi: 10.1038/s41575-020-0350-4. Epub 2020 Aug 25.

本文引用的文献

1
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
2
Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children.不同产毒艰难梭菌菌株感染对儿童粪便微生物群的影响。
Sci Rep. 2014 Dec 15;4:7485. doi: 10.1038/srep07485.
3
Humoral immune response as predictor of recurrence in Clostridium difficile infection.体液免疫反应可预测艰难梭菌感染的复发。
Clin Microbiol Infect. 2014 Dec;20(12):1323-8. doi: 10.1111/1469-0691.12769. Epub 2014 Dec 12.
4
Multistate point-prevalence survey of health care-associated infections.多州医疗机构相关性感染的时点患病率调查。
N Engl J Med. 2014 Mar 27;370(13):1198-208. doi: 10.1056/NEJMoa1306801.
5
Age-dependent dysregulation of innate immunity.年龄相关的固有免疫失调。
Nat Rev Immunol. 2013 Dec;13(12):875-87. doi: 10.1038/nri3547. Epub 2013 Oct 25.
6
In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.体内生理和转录谱分析揭示了宿主对艰难梭菌毒素 A 和毒素 B 的反应。
Infect Immun. 2013 Oct;81(10):3814-24. doi: 10.1128/IAI.00869-13. Epub 2013 Jul 29.
7
Understanding immunosenescence to improve responses to vaccines.了解免疫衰老以提高疫苗反应。
Nat Immunol. 2013 May;14(5):428-36. doi: 10.1038/ni.2588. Epub 2013 Apr 18.
8
Effect of age on treatment outcomes in Clostridium difficile infection.年龄对艰难梭菌感染治疗效果的影响。
J Am Geriatr Soc. 2013 Feb;61(2):222-30. doi: 10.1111/jgs.12090. Epub 2013 Feb 4.
9
Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.万古霉素治疗与小鼠肠道组织损伤延迟、梭状芽孢杆菌过度生长和艰难梭菌感染复发的关系。
Antimicrob Agents Chemother. 2013 Feb;57(2):689-96. doi: 10.1128/AAC.00877-12. Epub 2012 Nov 12.
10
Deaths: final data for 2008.死亡情况:2008年最终数据。
Natl Vital Stat Rep. 2011 Dec 7;59(10):1-126.

万古霉素治疗改变艰难梭菌感染老年小鼠模型中的体液免疫和肠道微生物群。

Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.

作者信息

van Opstal Edward, Kolling Glynis L, Moore John H, Coquery Christine M, Wade Nekeithia S, Loo William M, Bolick David T, Shin Jae Hyun, Erickson Loren D, Warren Cirle A

机构信息

Department of Biology, Vanderbilt University, Nashville, Tennessee.

Department of Medicine.

出版信息

J Infect Dis. 2016 Jul 1;214(1):130-9. doi: 10.1093/infdis/jiw071. Epub 2016 Feb 24.

DOI:10.1093/infdis/jiw071
PMID:26917573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4907406/
Abstract

BACKGROUND

The elderly host is highly susceptible to severe disease and treatment failure in Clostridium difficile infection (CDI). We investigated how treatment with vancomycin in the aged host influences systemic and intestinal humoral responses and select intestinal microbiota.

METHODS

Young (age, 2 months) and aged (age, 18 months) C57BL/6 mice were infected with VPI 10463 after exposure to broad-spectrum antibiotics. Vancomycin was given 24 hours after infection, and treatment was continued for 5 days. At select time points, specimens of serum and intestinal tissue and contents were collected for histopathologic analysis, to measure antibody levels and the pathogen burden, and to determine the presence and levels of select intestinal microbiota and C. difficile toxin.

RESULTS

Levels of disease severity, relapse, and mortality were increased, and recovery from infection was slower in aged mice compared to young mice. Serum levels of immunoglobulin M, immunoglobulin A, and immunoglobulin G against C. difficile toxin A were depressed in aged mice, and vancomycin treatment reduced antibody responses in both age groups. While baseline levels of total bacterial load, Bacteroidetes, Firmicutes, and Enterobacteriaceae were mostly similar, aged mice had a significant change in the Firmicutes to Bacteroidetes ratio with vancomycin treatment.

CONCLUSIONS

Vancomycin treatment decreases the systemic humoral response to CDI. Increased mortality from and recurrence of CDI in the aged host are associated with an impaired humoral response and a greater susceptibility to vancomycin-induced alteration of intestinal microbiota.

摘要

背景

老年宿主在艰难梭菌感染(CDI)中极易发生重症疾病和治疗失败。我们研究了老年宿主中万古霉素治疗如何影响全身和肠道的体液反应以及特定肠道微生物群。

方法

将年轻(2个月龄)和老年(18个月龄)的C57BL/6小鼠在接触广谱抗生素后感染VPI 10463。感染后24小时给予万古霉素,并持续治疗5天。在选定的时间点,收集血清、肠道组织和内容物标本进行组织病理学分析,以测量抗体水平和病原体负荷,并确定特定肠道微生物群和艰难梭菌毒素的存在及水平。

结果

与年轻小鼠相比,老年小鼠的疾病严重程度、复发率和死亡率增加,感染恢复较慢。老年小鼠中针对艰难梭菌毒素A的免疫球蛋白M、免疫球蛋白A和免疫球蛋白G的血清水平降低,万古霉素治疗降低了两个年龄组的抗体反应。虽然总细菌负荷、拟杆菌门、厚壁菌门和肠杆菌科的基线水平大多相似,但万古霉素治疗后老年小鼠的厚壁菌门与拟杆菌门比例有显著变化。

结论

万古霉素治疗会降低对CDI的全身体液反应。老年宿主中CDI死亡率增加和复发与体液反应受损以及对万古霉素诱导的肠道微生物群改变更易感性有关。